Immune Buildings Designed to Combat Diseases and Chemical Warfare

Article

The Early Warning and Response system (eWAR). Courtesy of University of Saskatchewan.

 

 

Researchers at the University of Saskatchewan have opened a new engineering lab to design a ventilation system that could protect schools, hospitals, and other public buildings from chemical warfare and bioterrorist attacks.

“Think of it as a complex fire alarm for industrial chemical spills, airborne diseases, and biological warfare strikes on vulnerable public spaces,” says engineering dean and lead researcher Janusz Kozinski.

“Whether an emergency starts with a terrorist’s biowarfare assault or a contagious disease seeping through a hospital’s air ducts, time is of the essence,” adds Kozinski. “This system promises to give citizens and emergency workers in these scenarios the extra seconds they need to respond before it’s too late.”

The Early Warning and Response system (eWAR) addresses what Kozinski views as major threats to public safety — the release of noxious chemicals and bio-agents into public buildings either accidentally through industrial spills or purposely through bioterrorist assaults that target ventilation systems. It could also address the threat of outbreaks by detecting diseases, such as chickenpox and tuberculosis, before they spread through a hospital’s air vents.

The new lab-scale set-up includes a model Heat Ventilation and Air Conditioning (HVAC) system that runs different simulations of potential building contamination scenarios. Using the model HVAC system, Kozinski and his colleagues will further investigate how humidity, air pressure, wind, and temperature influence the spread of noxious fumes and biochemical agents.

The lab’s research will help determine how eWAR can both filter harmful agents out of the air and activate warnings when airborne contaminants reach a critical density. In its current design, eWAR quickly notifies building residents about potential threats and conserves energy by only activating in times of potential crisis.

“We are expanding the scope of eWAR applications to cover a wider base of situations that may affect civilian populations, such as the spread of influenza, anthrax, or nerve agent sarin,” says Andre Dascal, a McGill University associate professor of medicine, microbiology, and immunology collaborating on the project.

Once fully developed, eWAR is expected to fill a gap in the biodefense marketplace, where maintaining bio-security in public buildings is not economically feasible using current technologies. An integrated eWAR system could make detecting the myriad chemicals and bio-agents part of normal security procedures, essentially creating “immune buildings.”

“Shopping malls, government facilities, and commercial buildings are all waiting for a system like eWAR to give first responders enough time to evacuate people from public places before they are exposed to dangerous chemicals and biohazards,” says Suzanne L. Lebel, Chairman of Alert B & C. “As partners in the eWAR project, we will use our TRAKERTM instruments to rapidly detect and identify harmful agents.”

The eWAR project is a research consortium formed by the U of S, McGill University, Concordia University, the Biotechnology Research Institute, the Directorate of Public Health of Montreal, UV-Sterisource, and ALERT B & C.

Source: University of Saskatchewan

 

 

 

 

 

Recent Videos
Lindsay K. Weir, MPH, CIC, Lead Infection Preventionist/Infection Preventionist III
•	Rebecca (Bartles) Crapanzano-Sigafoos, DrPH, MPH, CIC, FAPIC (corresponding author), executive director of APIC’s Center for Research, Practice, and Innovation, and lead author of the study.
Infection Control Today's Infection Intel: Staying Ahead With Company Updates and Product Innovations.
COVID-19 presentations at IDWeek in Las Angeles, California by Invivyd.   (Adobe Stock 333039083 by Production Perig)
Long COVID and Other Post-Viral Syndromes
Meet Jenny Hayes, MSN, RN, CIC, CAIP, CASSPT.
Infection Control Today Editorial Advisory Board: Fibi Attia, MD, MPH, CIC.
Andrea Thomas, PhD, DVM, MSc, BSc, director of epidemiology at BlueDot
mpox   (Adobe Stock 924156809 by Andreas Prott)
Meet Alexander Sundermann, DrPH, CIC, FAPIC.
Related Content